Alnylam Pharmaceuticals
Min Tan is an accomplished scientist with extensive experience in the biopharmaceutical field, currently serving as a Principal Scientist at Alnylam Pharmaceuticals. Prior roles include Senior Scientist and Scientist at the same company, as well as a Postdoctoral researcher at Harvard Medical School and Research Associate at Shanghai Institute of Biochemistry & Cell Biology. Min Tan holds a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from Shanghai Institute of Biochemistry & Cell Biology, earned between 2006 and 2011, and a Bachelor's degree in Biotechnology from Nanjing University, completed in 2006.
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.